Amgen Revenue 2006-2020 | AMGN

Amgen annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Amgen revenue for the quarter ending June 30, 2020 was $6.206B, a 5.71% increase year-over-year.
  • Amgen revenue for the twelve months ending June 30, 2020 was $24.301B, a 3.14% increase year-over-year.
  • Amgen annual revenue for 2019 was $23.362B, a 1.62% decline from 2018.
  • Amgen annual revenue for 2018 was $23.747B, a 3.93% increase from 2017.
  • Amgen annual revenue for 2017 was $22.849B, a 0.62% decline from 2016.
Amgen Annual Revenue
(Millions of US $)
2019 $23,362
2018 $23,747
2017 $22,849
2016 $22,991
2015 $21,662
2014 $20,063
2013 $18,676
2012 $17,265
2011 $15,582
2010 $15,053
2009 $14,642
2008 $15,003
2007 $14,771
2006 $14,268
2005 $12,430
Amgen Quarterly Revenue
(Millions of US $)
2020-06-30 $6,206
2020-03-31 $6,161
2019-12-31 $6,197
2019-09-30 $5,737
2019-06-30 $5,871
2019-03-31 $5,557
2018-12-31 $6,230
2018-09-30 $5,904
2018-06-30 $6,059
2018-03-31 $5,554
2017-12-31 $5,802
2017-09-30 $5,773
2017-06-30 $5,810
2017-03-31 $5,464
2016-12-31 $5,965
2016-09-30 $5,811
2016-06-30 $5,688
2016-03-31 $5,527
2015-12-31 $5,536
2015-09-30 $5,723
2015-06-30 $5,370
2015-03-31 $5,033
2014-12-31 $5,331
2014-09-30 $5,031
2014-06-30 $5,180
2014-03-31 $4,521
2013-12-31 $5,011
2013-09-30 $4,748
2013-06-30 $4,679
2013-03-31 $4,238
2012-12-31 $4,421
2012-09-30 $4,319
2012-06-30 $4,477
2012-03-31 $4,048
2011-12-31 $3,973
2011-09-30 $3,944
2011-06-30 $3,959
2011-03-31 $3,706
2010-12-31 $3,841
2010-09-30 $3,816
2010-06-30 $3,804
2010-03-31 $3,592
2009-12-31 $3,809
2009-09-30 $3,812
2009-06-30 $3,713
2009-03-31 $3,308
2008-12-31 $3,751
2008-09-30 $3,875
2008-06-30 $3,764
2008-03-31 $3,613
2007-12-31 $3,745
2007-09-30 $3,611
2007-06-30 $3,728
2007-03-31 $3,687
2006-12-31 $3,835
2006-09-30 $3,612
2006-06-30 $3,604
2006-03-31 $3,217
2005-12-31 $3,271
2005-09-30 $3,154
2005-06-30 $3,172
2005-03-31 $2,833
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $141.574B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.998B 11.09
CSL (CSLLY) Australia $92.626B 0.00
Gilead Sciences (GILD) United States $86.306B 12.43
Vertex Pharmaceuticals (VRTX) United States $70.548B 39.37
Regeneron Pharmaceuticals (REGN) United States $67.370B 24.91
Illumina (ILMN) United States $50.589B 58.43
Biogen (BIIB) United States $46.421B 7.94
Seattle Genetics (SGEN) United States $27.629B 0.00
Moderna (MRNA) United States $27.432B 0.00
Genmab (GMAB) Denmark $23.773B 19.56
Alexion Pharmaceuticals (ALXN) United States $22.527B 9.39
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.281B 0.00
Genmab (GNMSF) Denmark $21.968B 65.22
BioMarin Pharmaceutical (BMRN) United States $21.403B 155.29
Incyte (INCY) United States $20.606B 0.00
BeiGene (BGNE) Cayman Islands $19.054B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.852B 0.00
BioNTech SE (BNTX) Germany $15.637B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.061B 68.12
Horizon Therapeutics Public (HZNP) Ireland $14.999B 35.10
Exact Sciences (EXAS) United States $13.087B 0.00
Galapagos (GLPG) Belgium $12.406B 44.95
Sarepta Therapeutics (SRPT) United States $12.404B 0.00
QIAGEN (QGEN) Netherlands $11.028B 27.99
ARGENX SE-ADR (ARGX) Netherlands $10.912B 0.00
Bio-Techne Corp (TECH) United States $10.069B 69.69
Immunomedics (IMMU) United States $9.389B 0.00
Guardant Health (GH) United States $8.626B 0.00
Novavax (NVAX) United States $7.624B 0.00
Repligen (RGEN) United States $7.504B 119.11
Ascendis Pharma (ASND) Denmark $7.451B 0.00
Emergent Biosolutions (EBS) United States $6.857B 27.16
Exelixis (EXEL) United States $6.755B 24.56
Vir Biotechnology (VIR) United States $6.717B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.407B 198.50
SWEDISH ORP BIO (BIOVF) Sweden $6.375B 15.86
ACADIA Pharmaceuticals (ACAD) United States $6.285B 0.00
Mirati Therapeutics (MRTX) United States $5.861B 0.00
Acceleron Pharma (XLRN) United States $5.522B 0.00
MyoKardia (MYOK) United States $5.381B 0.00
Adaptive Biotechnologies (ADPT) United States $5.209B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.078B 0.00
Zai Lab (ZLAB) China $4.628B 0.00
NeoGenomics (NEO) United States $4.413B 1332.00
MorphoSys AG (MOR) Germany $4.282B 56.12
China Biologic Products (CBPO) China $4.175B 23.21
Blueprint Medicines (BPMC) United States $4.100B 0.00
Bluebird Bio (BLUE) United States $4.091B 0.00
Halozyme Therapeutics (HALO) United States $3.913B 0.00
Amicus Therapeutics (FOLD) United States $3.783B 0.00
Global Blood Therapeutics (GBT) United States $3.782B 0.00
Arena Pharmaceuticals (ARNA) United States $3.659B 0.00
Reata Pharmaceuticals (RETA) United States $3.434B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.417B 0.00
Denali Therapeutics (DNLI) United States $3.174B 0.00
Sorrento Therapeutics (SRNE) United States $3.004B 0.00
Insmed (INSM) United States $3.002B 0.00
Fate Therapeutics (FATE) United States $2.962B 0.00
Alkermes (ALKS) Ireland $2.960B 62.03
Principia Biopharma (PRNB) United States $2.900B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.644B 0.00
Amarin (AMRN) Ireland $2.552B 0.00
Twist Bioscience (TWST) United States $2.544B 0.00
Inovio Pharmaceuticals (INO) United States $2.303B 0.00
Editas Medicine (EDIT) United States $2.164B 0.00
Viela Bio (VIE) United States $1.959B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
UniQure (QURE) Netherlands $1.846B 0.00
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 60.74
Seres Therapeutics (MCRB) United States $1.797B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.762B 0.00
I-Mab (IMAB) China $1.675B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
Eidos Therapeutics (EIDX) United States $1.633B 0.00
Revance Therapeutics (RVNC) United States $1.623B 0.00
Cytokineticsorporated (CYTK) United States $1.545B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.466B 0.00
Zealand Pharma (ZEAL) Denmark $1.423B 0.00
Zymeworks (ZYME) Canada $1.382B 0.00
Mesoblast (MESO) Australia $1.379B 0.00
Coherus BioSciences (CHRS) United States $1.351B 7.88
Forma Therapeutics Holdings (FMTX) United States $1.326B 0.00
Intra-Cellular Therapies (ITCI) United States $1.302B 0.00
Epizyme (EPZM) United States $1.293B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
NGM Biopharmaceuticals (NGM) United States $1.261B 0.00
Mersana Therapeutics (MRSN) United States $1.244B 0.00
REGENXBIO (RGNX) United States $1.215B 0.00
Adverum Biotechnologies (ADVM) United States $1.202B 0.00
Compugen (CGEN) Israel $1.201B 0.00
Intellia Therapeutics (NTLA) United States $1.199B 0.00
Akcea Therapeutics (AKCA) United States $1.158B 0.00
Alcobra (ARCT) United States $1.153B 0.00
Beam Therapeutics (BEAM) United States $1.147B 0.00
Arcus Biosciences (RCUS) United States $1.139B 0.00
Arvinas (ARVN) United States $1.084B 0.00
Alector (ALEC) United States $1.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.029B 0.00
NantKwest (NK) United States $1.005B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.976B 0.00
Myriad Genetics (MYGN) United States $0.974B 50.27
Heska (HSKA) United States $0.965B 0.00
Athenex (ATNX) United States $0.949B 0.00
Retrophin (RTRX) United States $0.937B 0.00
Morphic Holding (MORF) United States $0.858B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.838B 0.00
Castle Biosciences (CSTL) United States $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Pharming Group (PHGUF) Netherlands $0.807B 18.43
Cara Therapeutics (CARA) United States $0.798B 0.00
Codexis (CDXS) United States $0.791B 0.00
Dynavax Technologies (DVAX) United States $0.755B 0.00
Intrexon (PGEN) United States $0.748B 0.00
Frequency Therapeutics (FREQ) United States $0.719B 0.00
Cellectis S.A (CLLS) France $0.713B 0.00
Vericel (VCEL) United States $0.711B 0.00
Kadmon Holdings (KDMN) United States $0.710B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.695B 0.00
MiMedx (MDXG) United States $0.686B 0.00
Biofrontera AG (BFRA) Germany $0.684B 0.00
Agenus (AGEN) United States $0.653B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.651B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.650B 5.69
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.614B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.586B 0.00
Syros Pharmaceuticals (SYRS) United States $0.554B 0.00
MeiraGTx Holdings (MGTX) United States $0.532B 0.00
Kala Pharmaceuticals (KALA) United States $0.512B 0.00
Anika Therapeutics (ANIK) United States $0.507B 22.16
Prothena (PRTA) Ireland $0.503B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Innate Pharma S.A (IPHA) France $0.482B 0.00
Cel-Sci (CVM) United States $0.480B 0.00
Protagonist Therapeutics (PTGX) United States $0.467B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.462B 32.68
Aquinox Pharmaceuticals (NLTX) United States $0.460B 0.00
Athersys (ATHX) United States $0.456B 0.00
Avid Bioservices (CDMO) United States $0.455B 0.00
AC Immune SA (ACIU) Switzerland $0.451B 0.00
Pfenex (PFNX) United States $0.442B 0.00
Clovis Oncology (CLVS) United States $0.431B 0.00
Prometic Life Sciences (LMNL) Canada $0.414B 0.00
Scholar Rock Holding (SRRK) United States $0.394B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.394B 0.00
Puma Biotechnology (PBYI) United States $0.394B 0.00
ANI Pharmaceuticals (ANIP) United States $0.390B 9.19
PDL BioPharma (PDLI) United States $0.377B 0.00
Merus (MRUS) Netherlands $0.377B 0.00
Cellular Biomedicine (CBMG) United States $0.374B 0.00
MannKind (MNKD) United States $0.374B 0.00
Albireo Pharma (ALBO) United States $0.367B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.366B 0.00
Kamada (KMDA) Israel $0.358B 17.13
Precision BioSciences (DTIL) United States $0.346B 0.00
WAVE Life Sciences (WVE) Singapore $0.339B 0.00
Geron (GERN) United States $0.333B 0.00
CytomX Therapeutics (CTMX) United States $0.327B 0.00
Trevena (TRVN) United States $0.301B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
ChromaDex (CDXC) United States $0.301B 0.00
IBio (IBIO) United States $0.290B 0.00
Arbutus Biopharma (ABUS) United States $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.284B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
Selecta Biosciences (SELB) United States $0.277B 0.00
Starpharma Holdings (SPHRY) Australia $0.271B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Menlo Therapeutics (MNLO) United States $0.267B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Verastem (VSTM) United States $0.261B 0.00
NextCure (NXTC) United States $0.261B 0.00
Affimed (AFMD) Germany $0.255B 0.00
DBV Technologies S.A (DBVT) France $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.251B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Dyadic (DYAI) United States $0.241B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Northwest Biotherapeutics (NWBO) United States $0.233B 0.00
Celldex Therapeutics (CLDX) United States $0.230B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
Pluristem Therapeutics (PSTI) Israel $0.223B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Sutro Biopharma (STRO) United States $0.207B 0.00
Exicure (XCUR) United States $0.200B 0.00
Aduro Biotech (ADRO) United States $0.200B 0.00
XOMA (XOMA) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.199B 9.30
Nymox Pharmaceutical (NYMX) Canada $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.193B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Cyclerion Therapeutics (CYCN) United States $0.179B 0.00
Aptinyx (APTX) United States $0.176B 0.00
Five Prime Therapeutics (FPRX) United States $0.175B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.170B 0.00
VTv Therapeutics (VTVT) United States $0.169B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
Aytu Bioscience (AYTU) United States $0.158B 0.00
Bellus Health (BLU) Canada $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.155B 0.00
TELA Bio (TELA) United States $0.150B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
VolitionRX (VNRX) United States $0.139B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.137B 0.00
Gritstone Oncology (GRTS) United States $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.129B 0.00
Cardiff Oncology (CRDF) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 6.45
Palatin Technologies (PTN) United States $0.127B 3.25
Lumos Pharma (LUMO) United States $0.125B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
CorMedix Inc (CRMD) United States $0.124B 0.00
Protalix BioTherapeutics (PLX) Israel $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.120B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.118B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.104B 0.00
Antibe Therapeutics (ATBPF) Canada $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.090B 0.00
Organovo Holdings (ONVO) United States $0.090B 0.00
AquaBounty Technologies (AQB) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
AnPac Bio-Medical Science (ANPC) China $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
DiaMedica Therapeutics (DMAC) United States $0.075B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.064B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 90.00
Aerpio Pharmaceuticals (ARPO) United States $0.062B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
Genetic Technologies (GENE) Australia $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Novogen (KZIA) Australia $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Spherix (AIKI) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Chanticleer Holdings (SONN) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00